Tower Bridge Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Buy
71,531
+630
+0.9% +$96.6K 1.06% 28
2025
Q4
$9.78M Sell
70,901
-2,437
-3% -$319K 0.99% 29
2025
Q3
$9.4M Sell
73,338
-1,006
-1% -$123K 0.94% 32
2025
Q2
$9M Sell
74,344
-3,591
-5% -$405K 0.97% 31
2025
Q1
$8.69M Sell
77,935
-1,368
-2% -$146K 0.97% 32
2024
Q4
$7.72M Sell
79,303
-2,033
-2% -$217K 0.82% 40
2024
Q3
$9.36M Sell
81,336
-2,026
-2% -$230K 0.97% 31
2024
Q2
$8.87M Sell
83,362
-1,606
-2% -$161K 0.99% 33
2024
Q1
$8.22M Sell
84,968
-6,042
-7% -$619K 0.84% 36
2023
Q4
$9.19M Sell
91,010
-1,068
-1% -$103K 0.79% 37
2023
Q3
$9.38M Sell
92,078
-1,131
-1% -$115K 0.87% 35
2023
Q2
$9.41M Sell
93,209
-12,440
-12% -$1.24M 0.86% 35
2023
Q1
$9.72M Sell
105,649
-2,471
-2% -$216K 0.8% 32
2022
Q4
$9.81M Sell
108,120
-2,530
-2% -$213K 0.81% 33
2022
Q3
$8.41M Sell
110,650
-2,993
-3% -$248K 0.75% 40
2022
Q2
$9.61M Sell
113,643
-1,526
-1% -$134K 0.78% 36
2022
Q1
$10.1M Sell
115,169
-3,941
-3% -$341K 0.68% 46
2021
Q4
$10.4M Sell
119,110
-17,984
-13% -$1.49M 0.64% 51
2021
Q3
$11.2M Sell
137,094
-2,547
-2% -$229K 0.75% 45
2021
Q2
$12.7M Sell
139,641
-2,544
-2% -$227K 0.85% 39
2021
Q1
$12.2M Sell
142,185
-3,283
-2% -$295K 0.92% 35
2020
Q4
$13.7M Buy
145,468
+2,945
+2% +$257K 1.12% 28
2020
Q3
$12.4M Buy
142,523
+3,693
+3% +$320K 1.27% 26
2020
Q2
$12.1M Buy
138,830
+8,506
+7% +$734K 1.36% 25
2020
Q1
$10.7M Buy
130,324
+9,557
+8% +$853K 1.41% 22
2019
Q4
$11.4M Buy
120,767
+7,048
+6% +$632K 1.21% 28
2019
Q3
$10M Buy
113,719
+2,425
+2% +$218K 1.1% 32
2019
Q2
$10.2M Sell
111,294
-12,586
-10% -$1.07M 1.14% 28
2019
Q1
$10.7M Buy
123,880
+697
+0.6% +$56K 1.24% 26
2018
Q4
$9.47M Buy
123,183
+155
+0.1% +$12.1K 1.22% 29
2018
Q3
$9.5M Buy
123,028
+5,407
+5% +$400K 0.99% 36
2018
Q2
$7.96M Sell
117,621
-4,412
-4% -$304K 0.89% 42
2018
Q1
$8.84M Buy
122,033
+5,735
+5% +$437K 0.98% 39
2017
Q4
$8.75M Buy
116,298
+5,955
+5% +$449K 0.94% 39
2017
Q3
$8.49M Buy
110,343
+8,255
+8% +$623K 0.96% 42
2017
Q2
$7.64M Sell
102,088
-21,115
-17% -$1.5M 0.88% 46
2017
Q1
$8.2M Sell
123,203
-15,058
-11% -$1M 0.96% 38
2016
Q4
$9.02M Sell
138,261
-46,756
-25% -$3.03M 1.09% 33
2016
Q3
$13.1M Buy
185,017
+905
+0.5% +$65.9K 1.59% 19
2016
Q2
$13.6M Buy
184,112
+2,647
+1% +$183K 1.7% 15
2016
Q1
$11.8M Buy
181,465
+6,342
+4% +$431K 1.47% 21
2015
Q4
$13.5M Buy
175,123
+5,754
+3% +$457K 1.76% 15
2015
Q3
$14M Buy
169,369
+971
+0.6% +$86.4K 1.92% 10
2015
Q2
$14.8M Sell
168,398
-499
-0.3% -$45.8K 1.88% 11
2015
Q1
$14.9M Buy
168,897
+12,940
+8% +$1.15M 1.89% 7
2014
Q4
$12.9M Buy
155,957
+1,284
+0.8% +$106K 1.59% 17
2014
Q3
$13M Sell
154,673
-2,869
-2% -$232K 1.65% 15
2014
Q2
$12.8M Sell
157,542
-3,500
-2% -$275K 1.58% 16
2014
Q1
$12.3M Buy
161,042
+1,358
+0.9% +$99K 1.58% 18
2013
Q4
$11.5M Sell
159,684
-258
-0.2% -$17.9K 1.51% 22
2013
Q3
$11M Buy
159,942
+329
+0.2% +$21.8K 1.58% 20
2013
Q2
$10.1M Buy
+159,613
New +$10.4M 1.5% 19

Other funds holding NVS

Tower Bridge Advisors's NVS Position: Q1 2026 in Review

Tower Bridge Advisors increased its Novartis (NVS) stake by 0.89% in Q1 2026, buying an estimated $96.6K and bringing the position to 71,531 shares worth $10.9M. The position accounts for 1.06% of the portfolio, ranked #28.

Tower Bridge Advisors first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.9M in Q1 2015. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Tower Bridge Advisors held 71,531 shares of Novartis worth $10.9M as of Q1 2026.
  • Tower Bridge Advisors bought 630 Novartis shares in Q1 2026, an estimated $96.6K.
  • Novartis made up 1.06% of Tower Bridge Advisors's portfolio in Q1 2026, its #28 holding.
  • Tower Bridge Advisors first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Tower Bridge Advisors's Novartis position peaked at $14.9M in Q1 2015.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.